An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.

Biguanides are a class of oral hypoglycemic agents, including metformin, which primarily reduce blood glucose levels by decreasing hepatic gluconeogenesis and increasing insulin sensitivity, but not by stimulating insulin secretion, and they are commonly used in the treatment of type 2 diabetes.

Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as DIABETES MELLITUS; LEUKEMIA; or LIVER FAILURE.